Search - tctmd.com

Displaying 61 - 80 of 402

Sort: Relevancy | Date

News Conference News TCT 2024

DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI

Todd Neale

October 29, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News ESC 2024

OCCUPI: OCT Guidance Improves Outcomes in Complex PCI

Shelley Wood

September 03, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

Caitlin E. Cox

August 16, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Daily News

Certain Periprocedural MIs Don’t Matter, New Data Allege

Michael O'Riordan

May 09, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

Advertisement

DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

OCCUPI: OCT Guidance Improves Outcomes in Complex PCI

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

DES Best for In-Stent Restenosis, but DCBs Also Viable

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Certain Periprocedural MIs Don’t Matter, New Data Allege

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

FDA Approves Bioresorbable Scaffold for BTK Lesions

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content